Trading window closure ahead of Q2 results

Compliance View source PDF Explain this filing

PGHL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.7%Reaction day

₹5400.00

prior close

₹5400.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.6%+3.3% vs market

Pharmaceuticals peers, median of 172sector-1.5%+3.2% vs sector

On the reaction day the stock moved 3.3 pts more than Nifty Microcap 250 and 3.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.2

10m

-0.1

15m

-0.3

30m

-0.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.7-1.6+3.3-1.5+3.2

Next day

+3.9-0.6+4.5-1.0+4.9

+3.1-0.8+4.0-1.9+5.0

-1.1-2.1+1.0-2.5+1.4

-1.9-2.1+0.3-3.4+1.5

-1.9-0.8-1.0-2.4+0.6

-4.2-3.8-0.4-4.3+0.0

15d

-6.6-6.9+0.3-7.9+1.3

+0.1pendingpending-6.6+6.7

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Procter and Gamble Health has informed the exchange that its trading window for directors and designated employees will be closed from October 1, 2026, until 48 hours after the publication of unaudited financial results for the quarter and half year ended September 30, 2026. This is a routine compliance measure under SEBI insider trading regulations ahead of the Q2 earnings announcement.

Likely market impact

Routine compliance filing. No material impact. Insiders barred from trading until Q2 results are published.